Related Experiment Video
Updated: Feb 22, 2026
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
Published on: March 7, 2017
Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies
Michaël H Meel1, A Charlotte P Sewing1, Piotr Waranecki1
1Departments of Pediatric Oncology / Hematology, Neuro-oncology Research Group, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands.
Abstract:
Diffuse intrinsic pontine glioma (DIPG) is an aggressive type of brainstem cancer occurring mainly in children, for which there currently is no effective therapy. Current efforts to develop novel therapeutics for this tumor make use of primary cultures of DIPG cells, maintained either as adherent monolayer in serum containing medium, or as neurospheres in serum-free medium. In this manuscript, we demonstrate that the response of DIPG cells to targeted therapies in vitro is mainly determined by the culture conditions. We show that particular culture conditions induce the activation of different receptor tyrosine kinases and signal transduction pathways, as well as major changes in gene expression profiles of DIPG cells in culture. These differences correlate strongly with the observed discrepancies in response to targeted therapies of DIPG cells cultured as either adherent monolayers or neurospheres. With this research, we provide an argument for the concurrent use of both culture conditions to avoid false positive and false negative results due to the chosen method.
Insights
Culture conditions significantly impact diffuse intrinsic pontine glioma (DIPG) cell response to targeted therapies. Using both adherent monolayers and neurospheres is crucial for accurate in vitro therapeutic evaluation of DIPG.
Area of Science:
- Oncology
- Cell Biology
- Neuroscience
Background:
- Diffuse intrinsic pontine glioma (DIPG) is a pediatric brainstem cancer with no effective treatments.
- Current research relies on in vitro models using DIPG cells cultured as adherent monolayers or neurospheres.
Purpose of the Study:
- To investigate how different in vitro culture conditions affect DIPG cell response to targeted therapies.
- To understand the molecular mechanisms underlying these culture-dependent differences.
Main Methods:
- Culturing DIPG cells as adherent monolayers and neurospheres.
- Assessing the response of these cultures to targeted therapies.
- Analyzing receptor tyrosine kinase activation, signal transduction pathways, and gene expression profiles.
Main Results:
- Culture conditions significantly alter DIPG cell responses to targeted therapies.
- Adherent and neurosphere cultures exhibit distinct activation of signaling pathways and gene expression profiles.
- These molecular differences correlate with observed variations in therapeutic response.
Conclusions:
- In vitro culture methods critically influence DIPG cell behavior and drug response.
- Concurrent use of both adherent monolayer and neurosphere culture conditions is recommended to obtain reliable and comprehensive results.
- This approach helps mitigate false positive and false negative findings in DIPG therapeutic development.
